TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS SY ICB -Community Pharmacy COVID-19 Triage, Assessment & Prescribing Service

Pharmacy services
Published value
£40,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS South Yorkshire Integrated Care Board: "NHS SY ICB -Community Pharmacy COVID-19 Triage, Assessment & Prescribing Service". Published status: complete. Published value: £40,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS South Yorkshire Integrated Care BoardScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£40,000
Bidder Intelligence · Authority Profile: NHS South Yorkshire Integrated Care Board
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS South Yorkshire Integrated Care Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
99.5% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 651 active published awards; 645 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published22 Apr 2026, 15:32 BST
Last source update22 Apr 2026, 15:32 BST
Recurring procurementNot published
ClassificationPharmacy services
OCIDocds-h6vhtk-066c8c
What is being bought
Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19.
What changed
From the official release history
  1. tender value changed
    22 Apr 2026, 15:32 BST
  2. Status changed to complete
    22 Apr 2026, 15:32 BST
  3. Official notice release published
    22 Apr 2026, 15:32 BST
  4. Published value updated to £40,000
    17 Mar 2026, 15:30 GMT
  5. Status changed to planned
    17 Mar 2026, 15:30 GMT
  6. Official notice release published
    17 Mar 2026, 15:30 GMT
  7. Buyer information updated
    17 Mar 2026, 15:30 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19.<br/><br/>This notice is an intention to award a contract under the most suitable provider process.<br/><br/>The approximate lifetime value of the service is £40,000.<br/><br/>This is a new service.<br/><br/>The service will run from 01/06/2026 to 31/05/2028
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    22 Apr 2026, 15:32 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 21 Apr 2026, 00:00 BST · £40,000
Commercial outcome and competition
Awards
Associated Chemists (Wicker) Ltd
Not published · Not published · active
Contracts
Contract
£40,000 · signed 21 Apr 2026, 00:00 BST · active
Bid statistics
bids: 8 (lot 1)
smeBids: 8 (lot 1)
Buyer and organisations in this procedure

NHS South Yorkshire Integrated Care Board

Contracting authority GB-FTS-113634
View buyer profile
  • NHS South Yorkshire Integrated Care Board
    buyer

    197 Eyre Street, Sheffield, UKE32, S1 3FG
  • Associated Chemists (Wicker) Ltd
    supplier

    00496833
    61-65 Wicker Sheffield, Sheffield, UKE32, S3 8HT
    +44 1142727676
  • Independent Choice and Procurement Panel.
    reviewBody

    Wellington House, London, SE1 8UG
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThis is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2024 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 5th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>The decision maker was: SY Integrated Pharmacy and Medicines Optimisation Programme Manager<br/><br/>No conflicts of interest were identified.<br/><br/>A F01 PIN notice (2026/S 000-024193) was published on 17th March 2026 asking potential providers for the service to responde to 6 questions, relating to providing the service. This was treated as a market engagement exercise to identify any providers that SY ICB were not aware of.<br/><br/>The 6 questions were:<br/><br/>1. Mobilisation - Key Criteria 4 - improving access, reducing health inequalities and facilitating choice.<br/>2. Service Delivery - Key Criteria 3 - integration, collaboration and service sustainability<br/>3. Organisational Details - Key Criteria 1 – Quality & Innovation<br/>4. Business Continuity - Key criteria 4 - improving access, reducing health inequalities and facilitating choice<br/>5. Value - Key Criteria 2. Value<br/>6. Social Value - Key Criteria 5 Social Value<br/><br/>All submissions were evaluated and moderated to provide a score for each provider's submission and the submission with the highest moderated score has been appointed as the preferred supplier. It is the intention to award the contract to this preferred supplier.